---
figid: PMC11475022__PUL2-14-e12439-g004
figtitle: GSEA of 18 patients with CTEPH from the GEO database
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11475022
filename: PUL2-14-e12439-g004.jpg
figlink: /pmc/articles/PMC11475022/figure/F6/
number: F6
caption: 'GSEA of 18 patients with CTEPH from the GEO database. (a) GSEA identified
  five pathways significantly associated with high ERBB4 expression, including CHOLESTEROL
  HOMEOSTASIS, OXIDATIVE PHOSPHORYLATION, and FATTY ACID METABOLISM (p < 0.05). (b)
  Three pathways are significantly associated with the high ERBB4 expression group:
  fatty acid metabolism, oxidative phosphorylation, and cholesterol homeostasis. CTEPH,
  chronic thromboembolic pulmonary hypertension; GEO, Gene Expression Omnibus; GSEA,
  gene set enrichment analysis'
papertitle: The influence of the NRG1/ERBB4 signaling pathway on pulmonary artery
  endothelial cells
reftext: Jin‐Bo Huang, et al. Pulm Circ. 2024 Oct;14(4).
year: '2024'
doi: 10.1002/pul2.12439
journal_title: Pulmonary Circulation
journal_nlm_ta: Pulm Circ
publisher_name: Wiley
keywords: chronic thromboembolic pulmonary hypertension | ERBB4 | human pulmonary
  artery endothelial cells | Neuregulin‐1
automl_pathway: 0.670625
figid_alias: PMC11475022__F6
figtype: Figure
redirect_from: /figures/PMC11475022__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11475022__PUL2-14-e12439-g004.html
  '@type': Dataset
  description: 'GSEA of 18 patients with CTEPH from the GEO database. (a) GSEA identified
    five pathways significantly associated with high ERBB4 expression, including CHOLESTEROL
    HOMEOSTASIS, OXIDATIVE PHOSPHORYLATION, and FATTY ACID METABOLISM (p < 0.05).
    (b) Three pathways are significantly associated with the high ERBB4 expression
    group: fatty acid metabolism, oxidative phosphorylation, and cholesterol homeostasis.
    CTEPH, chronic thromboembolic pulmonary hypertension; GEO, Gene Expression Omnibus;
    GSEA, gene set enrichment analysis'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CENPF
  - ENO1
  - CLASRP
  - CTTN
  - CNTRL
  - SMC3
  - SSH2
  - ARHGEF12
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - GUSB
  - PMVK
  - TH
  - ALDOC
  - APC
  - PROC
  - TNFRSF12A
  - ATP8A2
  - PLA2G15
  - ACSS2
  - ACCS
  - CD74
  - POMC
  - CLIP1
  - CLIP2
  - CEP250
  - TUBGCP2
  - ADO
  - RASA1
  - RASA2
  - RASA3
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - TRIO
  - PKD2
  - PRKD2
  - S100A1
  - HRNR
  - S100A10
  - S100A11
  - S100A12
  - S100A13
  - S100A14
  - S100A16
  - S100A2
  - S100A3
  - S100A4
  - S100A5
  - S100A6
  - S100A7
  - S100A7A
  - S100A8
  - S100A9
  - TCHHL1
  - EBP
  - GLB1
  - SH3D19
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - CDK13
  - ATRN
  - COL1A2
  - ABCC1
  - RIBC2
  - MAL
  - MRTFA
  - TIRAP
  - NEFL
  - STARD4
  - NIPBL
  - ACAT1
  - CES1
  - SOAT1
  - HMGCS1
  - FADS2
  - RAPSN
  - SNAI1
  - CST8
  - CFD
  - FHL2
  - TIE1
  - GSTZ1
  - CYBA
  - ACSL1
  - ACSL3
  - ACSL4
  - ACSL5
  - ACSL6
  - BCKDHB
  - PTS
  - C1QTNF3
  - ALDOA
  - SMS
  - RAI1
  - SURF1
  - SDHA
  - CRABP1
  - CRABP2
  - FABP1
  - FABP12
  - FABP2
  - FABP3
  - FABP4
  - FABP5
  - FABP6
  - FABP7
  - FABP9
  - PMP2
  - RBP1
  - RBP2
  - RBP5
  - RBP7
  - SPATA2
  - SPATA2L
  - GSTA1
  - GSTA2
  - MGST2
  - CHST2
  - GSPT2
  - CRAT
  - MTX1
  - MRPS30
  - ACADM
  - BLVRA
  - GAPDHS
  - CPT2
  - POP1
  - BVES
  - PYDC1
  - IDH2
  - MRPS15
  - VDAC2
  - DLAT
  - FOXG1
  - FOXH1
  - FOXM1
  - FOXQ1
  - FOXS1
  - FOXA1
  - FOXA2
  - FOXA3
  - FOXB1
  - FOXB2
  - FOXC1
  - FOXC2
  - FOXD1
  - FOXD2
  - FOXD3
  - FOXD4
  - FOXE1
  - FOXE3
  - FOXF1
  - FOXF2
  - FOXI1
  - FOXI2
  - FOXI3
  - FOXJ1
  - FOXJ2
  - FOXJ3
  - FOXK1
  - FOXK2
  - FOXL1
  - FOXL2
  - FOXN1
  - FOXN2
  - FOXN3
  - FOXN4
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - FOXP1
  - FOXP2
  - FOXP3
  - FOXP4
  - FOXR1
  - FOXR2
  - FOXD4L1
  - FOXD4L3
  - FOXD4L4
  - FOXD4L5
  - FOXD4L6
  - CUX1
  - CYTIP
  - CRTAP
  - ABL
  - ATP
  - ADO
  - TSC
  - MAL
  - MTX
---
